描述

Glimicron MR is a modified-release version of Gliclazide, formulated for once-daily dosing. This formulation allows for a controlled release of the active ingredient, ensuring stable blood glucose levels throughout a 24-hour period. It is specifically designed for Type 2 diabetes management, offering patients a convenient alternative to immediate-release tablets while maintaining consistent therapeutic efficacy and helping to prevent glucose spikes.

适用场景

Once Daily dosing preference, Stable blood sugar control, Type 2 diabetes management 和 Long Acting glycemic control

描述

Glimicron M is a dual-action combination therapy that integrates Gliclazide (80 mg) and Metformin (500 mg) into a single tablet. This combination medication is used for the treatment of Type 2 diabetes, providing a comprehensive approach by combining a sulfonylurea (to increase insulin production) with a biguanide (to reduce hepatic glucose production and improve insulin sensitivity). It is often utilized to simplify medication regimens for patients requiring multiple active ingredients for glycemic control.

适用场景

Dual Action diabetes treatment, Simplified medication regimens, Improving insulin sensitivity 和 Metformin and Gliclazide users

描述

Glimicron 80 mg is a prescription-only oral antidiabetic medication containing Gliclazide. As a sulfonylurea, it is used to manage Type 2 Diabetes Mellitus by stimulating the pancreas to secrete more insulin. Registered in Singapore under HSA Licence No. SIN09302P, this tablet is an essential therapeutic product for glycemic control in patients whose blood sugar is not sufficiently managed by diet and exercise alone.

适用场景

Type 2 diabetes patients, Blood glucose management, Prescription medication users 和 Sulfonylurea therapy